Showing results (531-540 of 608) with videos related to

Sort By:
Pageof 61
Transplantation|December 24, 2008
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejectionMatthew J Everly, Jason J Everly, Brian Susskind, et al.
Epidemiology (Cambridge, Mass.)|September 25, 2025
Illustrating an Adaptive Prespecification Framework for Observational Research: Target Trial Emulations Comparing Immunomodulator Treatments for COVID-19Andrew R Weckstein, Vera Frajzyngier, Sarah E Vititoe, et al.
Clinical Transplants|July 22, 2008
Corticosteroid elimination: the Cincinnati experienceE Steve Woodle, Rita Alloway, Adele Rike, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Addressing morbid obesity as a barrier to renal transplantation with laparoscopic sleeve gastrectomyC M Freeman, E S Woodle, J Shi, et al.
Open Forum Infectious Diseases|July 27, 2023
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021-February 2022Sarah E Vititoe, Priya Govil, Aidan Baglivo, et al.
Annals of Surgery|September 10, 2021
Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative RecipientsAaron M Delman, Kevin M Turner, Kamran Safdar, et al.
Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|March 10, 2023
Renal Replacement Therapy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice RecommendationRajesh C Mishra, Sharmili Sinha, Deepak Govil, et al.
Journal of Dental Research|June 1, 2010
Novel cleft susceptibility genes in chromosome 6qA Letra, R Menezes, R F Fonseca, et al.
Transplantation Proceedings|March 3, 2009
Proteasome inhibition reduces donor-specific antibody levelsM J Everly, J J Everly, B Susskind, et al.
American Heart Journal|June 5, 2025
Rationale, design, and baseline characteristics of the virtual care to improve heart failure outcomes (VITAL-HF) trialMirza S Khan, Andrew J Sauer, Cynthia L Green, et al.
Pageof 61